Clinical trial

Study of LX4211 in Subjects With Type 2 Diabetes Mellitus

NCT00962065

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2009-08-01

PhasePHASE2

Study timeline

Study start (unknown)2009-08-01Date precision: month

Registry last updated2011-03-03

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Type 2 Diabetes Mellitusunresolved

Interventions

LX4211 Low DoseDRUG

LX4211 High DoseDRUG

PlaceboDRUG

Sponsors & collaborators

Lexicon Pharmaceuticalslead sponsor

Mapped research locations

San AntonioTexas, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00962065 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.